Brightspring health services' specialty pharmacy onco360® celebrates excellent patient care and preferred pharmacy status

Louisville, ky., march 14, 2024 (globe newswire) -- brightspring health services (“brightspring” or “brightspring health services”) (nasdaq: btsg) announced today that its company, onco360®, one of the nation's largest independent oncology pharmacies, is now the national specialty pharmacy network partner for a first-in-class, xpo-1 inhibitor, xpovio® (selinexor) to treat patients with multiple myeloma. onco360® currently has 116 limited distribution drugs in its portfolio, in partnership with pharmaceutical and biotech companies.
BTSG Ratings Summary
BTSG Quant Ranking